Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: diagnostic

April 21, 2023 Drug delivery / Non-pharma applications / Other industrial use / Pharma applications

Special Issue: Cyclodextrin-Based Approach in Biotechnology

A special issue on cyclodextrin based approach in biotechnology to be published in Future Pharmacology (an international, scientific, peer-reviewed, open

Continue reading

November 2, 2022 Pharma applications

Application of cyclodextrin/polyethylene glycol in blood-storage tools for liquid biopsy

In recent years, liquid biopsy has garnered considerable attention as a valuable diagnostic technology for cancer. An analysis target of

Continue reading

November 12, 2019 Drug delivery / Pharma applications

Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

Ligand Pharmaceuticals Incorporated presented positive results from a Phase 1 clinical trial of its Captisol-enabled (CE) Iohexol program at ASN

Continue reading

October 28, 2019 Drug delivery / Pharma applications

Annual World Congress of Smart Materials

Field: AI and Robot / Composite Materials / IT and ICT / Energy Materials / Biomaterials / Photonic, Electronic and

Continue reading

May 3, 2019 Pharma applications

Enrollment completed of Phase 1 Clinical Trial of Captisol-enabled Iohexol

Ligand Pharmaceuticals Incorporated announced completion of enrollment of the Company’s Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol

Continue reading

August 28, 2018 Drug delivery / Pharma applications / Supramolecular systems

Cyclodextrins as theranostics

The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments

Continue reading

Recent Posts

  • Nano-Enabled Toxicity of Pharmaceutical Excipients
  • Cyclodextrins Across the Eye-Care Spectrum
  • Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs
  • CD-based supramolecular polymers based on host–guest interactions for cancer therapy
  • PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (66)
  • CD as API (347)
  • CD derivatives (410)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (790)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (221)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (398)
  • Other industrial use (106)
  • Pharma applications (1,180)
  • Supramolecular systems (40)
  • Uncategorized (146)

Top Posts

  • Nano-Enabled Toxicity of Pharmaceutical Excipients
  • Cyclodextrins Across the Eye-Care Spectrum
  • Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs
  • Antibody conjugated cyclodextrin for tumor drug delivery
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Are cyclodextrins safe for intravitreal injections?
  • CycloMolder software
  • Lanosterol eye drops for cataract treatment
  • Hybrid Cyclodextrin Nanosponges Meet Nanoporous Gold: A Step Forward in Sensing Platforms
  • How air fresheners work?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,473 other subscribers

Loading Comments...